NEWLINK GENETICS CORPORATION RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • August 5th, 2014 • Newlink Genetics Corp • Pharmaceutical preparations • Iowa
Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Restricted Stock Unit Award Agreement (the “Agreement”), NewLink Genetics Corporation (the “Company”) has awarded you (“Participant”) a Restricted Stock Unit Award (the “Award”) pursuant to Section 7(b) of the Company’s 2010 Non-Employee Director Stock Award Plan, as amended (the “Plan”) for the number of Restricted Stock Units/shares indicated in the Grant Notice. Capitalized terms not explicitly defined in this Agreement or the Grant Notice shall have the same meanings given to them in the Plan. The terms of your Award, in addition to those set forth in the Grant Notice, are as follows.
CELL THERAPY DEVELOPMENT, MANUFACTURING AND/OR TISSUE PROCESSING TERMS AND CONDITIONS BETWEEN WuXi AppTec, Inc. and NewLink Genetics CorporationDevelopment and Manufacturing Agreement • August 5th, 2014 • Newlink Genetics Corp • Pharmaceutical preparations • New York
This Development and Manufacturing Terms and Conditions (the “Agreement”) is made and entered into as of the date of the last signature on the signature page hereto (the “Effective Date”) by and between WuXi AppTec, Inc., a corporation organized under the laws of Delaware with offices located at 4751 League Island Blvd., Philadelphia, PA 19112 (“WuXi AppTec”), and NewLink Genetics Corporation, a company organized under the laws of Delaware with offices located at 2503 South Loop Drive, Suite 5100, Ames, IA 50010 and Affiliates (“Customer”). Customer and WuXi AppTec are referred to herein individually as a “Party” and collectively as the “Parties”.
